Costa Rica Coffee Guide

42% Say Yes to CAFTA Referendum

June 2, 2006

Forty-two percent of Costa Ricans polled in a recent survey said the decision to approve or reject the Central American Free-Trade Agreement with the United States (CAFTA) should not be decided by Congress, and instead should be voted on as a referendum issue, according to the daily La República.

Of those surveyed, 35% said the Legislative Assembly should decide on CAFTA, and the remaining 23% did not wish to express an opinion.

In February, legislators approved a bill to allow controversial topics to be brought to public vote through referendums (TT, March 3).

In the survey, carried out by CIDGallup for La República, 46% of those polled said CAFTA should be approved, while 23% said it should be rejected.

The survey, carried out from April 29 to May 4, polled 1,100 people all over the country and has a 3% margin of error.

Costa Rica is the only signatory country that has not ratified CAFTA. The Legislative Assembly has been discussing the agreement since October 2005.

 

You may be interested

Costa Rica coronavirus updates for Wednesday, September 30
Costa Rica
5587 views
Costa Rica
5587 views

Costa Rica coronavirus updates for Wednesday, September 30

Alejandro Zúñiga - September 30, 2020

Costa Rica announced 24 new coronavirus-related deaths over the last day for a total of 904, according to official data…

Some 34 million jobs lost in Latin America due to pandemic
Business
3341 views
Business
3341 views

Some 34 million jobs lost in Latin America due to pandemic

Carlos MANDUJANO / AFP - September 30, 2020

The two aspirers for the presidency of Costa Rica, the evangelical preacher Fabricio Alvarado and the former minister Carlos Alvarado, reach the closing of the electoral campaign for April 1st with a technical draw, according to a poll disclosed this Friday.

CureVac launches second stage of vaccine clinical trials in Peru and Panama
News
21363 views
News
21363 views

CureVac launches second stage of vaccine clinical trials in Peru and Panama

AFP - September 30, 2020

The German pharmaceutical company CureVac announced that it has started Phase 2 clinical trials of its experimental vaccine against Covid-19,…